cache/24df33b95ef7fad5ebffc803e0571b27affe2f30c1d8e401a39fef247353660f

COM:SAMSUNGBIOLOGICS

Samsung Biologics

  • Stock

Last Close

1.08M

25/09 06:30

Market Cap

58.01T

Beta: -

Volume Today

144.01K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
105.15B
-
91.28B
13.19%
294.62B
222.77%
464.63B
57.70%
535.81B
15.32%
701.59B
30.94%
1.16T
66.02%
1.57T
34.62%
3.00T
91.41%
3.69T
23.10%
cost of revenue
124.87B
-
114.78B
8.08%
268.09B
133.56%
332.83B
24.15%
390.65B
17.37%
509.58B
30.45%
748.70B
46.92%
841.56B
12.40%
1.53T
82.14%
1.89T
23.42%
gross profit
-19.72B
-
-23.51B
19.20%
26.53B
212.88%
131.80B
396.73%
145.16B
10.14%
192.01B
32.27%
416.08B
116.70%
726.45B
74.60%
1.47T
102.14%
1.80T
22.77%
selling and marketing expenses
20.79B
-
66.67B
220.76%
11.90B
82.15%
11.51B
3.25%
24.96B
116.81%
34.78B
39.32%
33.06B
4.95%
69.67B
110.75%
95.42B
36.96%
167.81B
75.87%
general and administrative expenses
20.52B
-
28.50B
38.92%
15.00B
47.38%
16.01B
6.73%
18.03B
12.66%
21.58B
19.65%
24.70B
14.48%
33.34B
34.97%
114.07B
242.14%
135.72B
18.98%
selling general and administrative expenses
41.30B
-
95.18B
130.43%
26.90B
71.74%
27.52B
2.31%
43.00B
56.23%
56.36B
31.07%
57.76B
2.49%
103.01B
78.34%
209.49B
103.37%
303.53B
44.89%
research and development expenses
186.74M
-
48.51B
-
5.11B
89.47%
75.96B
1,387.62%
45.88B
39.59%
81.59B
77.81%
other expenses
58.82B
-
2.43B
95.87%
1.18B
51.37%
758.69M
35.70%
-6.94B
1,014.39%
43.91B
732.88%
60.42B
37.62%
86.13B
42.55%
229.45B
166.39%
-2.58T
1,224.84%
cost and expenses
224.69B
-
294.92B
31.26%
325.04B
10.21%
398.65B
22.64%
480.13B
20.44%
609.85B
27.02%
871.99B
42.98%
1.03T
18.20%
2.02T
95.76%
2.58T
27.92%
operating expenses
99.82B
-
180.14B
80.46%
56.96B
68.38%
65.82B
15.56%
89.48B
35.95%
100.27B
12.05%
123.29B
22.96%
189.14B
53.41%
484.82B
156.33%
2.58T
432.34%
interest expense
2.47B
-
2.65B
7.32%
19.25B
626.45%
5.68B
70.48%
15.84B
178.65%
25.61B
61.72%
16.09B
37.20%
14.71B
8.57%
64.06B
335.60%
81.60B
27.37%
ebitda
-70.04B
-
4.35T
6,315.36%
-97.46B
102.24%
18.71B
119.20%
410.70B
2,094.85%
313.50B
23.67%
431.16B
37.53%
740.67B
71.78%
1.37T
85.37%
1.69T
23.38%
operating income
-119.54B
-
-203.64B
70.35%
-30.42B
85.06%
65.98B
316.88%
55.68B
15.61%
180.62B
224.39%
292.79B
62.10%
537.31B
83.52%
983.63B
83.07%
1.11T
13.22%
depreciation and amortization
26.35B
-
41.63B
57.98%
60.15B
44.49%
69.93B
16.25%
91.45B
30.78%
132.89B
45.31%
138.38B
4.13%
203.36B
46.96%
389.36B
91.46%
489.78B
25.79%
total other income expenses net
19.85B
-
2.69T
13,458.33%
-200.48B
107.45%
-181.97B
9.23%
247.30B
235.90%
-25.18B
110.18%
-26.79B
6.41%
23.97B
189.47%
25.40B
5.94%
6.31B
75.17%
income before tax
-99.69B
-
2.49T
2,595.84%
-230.90B
109.28%
-115.99B
49.76%
302.98B
361.20%
155.44B
48.70%
265.99B
71.13%
561.28B
111.01%
1.01T
79.77%
1.12T
11.00%
income tax expense
19.37B
-
583.12B
2,910.35%
-54.08B
109.27%
-19.02B
64.82%
78.87B
514.59%
-47.47B
160.19%
25.02B
152.70%
167.69B
570.31%
210.97B
25.81%
262.30B
24.33%
net income
-95.91B
-
1.90T
2,086.20%
-176.82B
109.28%
-96.97B
45.16%
224.11B
331.11%
202.90B
9.46%
240.97B
18.76%
393.59B
63.33%
798.06B
102.76%
857.69B
7.47%
weighted average shs out
17.24M
-
49.98M
189.83%
57.37M
14.78%
66.85M
16.53%
66.87M
0.03%
66.87M
0%
66.87M
0%
66.87M
0%
69.75M
4.31%
71.17M
2.05%
weighted average shs out dil
17.24M
-
49.98M
189.83%
57.37M
14.78%
66.85M
16.53%
66.87M
0.03%
66.87M
0.00%
66.87M
0%
66.87M
0%
69.81M
4.40%
71.17M
1.95%
eps
-5.56K
-
38.42K
790.77%
-3.08K
108.02%
-1.45K
52.94%
3.35K
331.05%
3.03K
9.46%
3.60K
18.76%
5.89K
63.33%
11.44K
94.39%
12.05K
5.31%
epsdiluted
-5.56K
-
38.42K
790.77%
-3.08K
108.02%
-1.45K
52.94%
3.35K
331.04%
3.03K
9.46%
3.60K
18.76%
5.89K
63.33%
11.43K
94.20%
12.05K
5.42%

All numbers in (except ratios and percentages)